Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020473 (
hyperlipidemia
)
15,891
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The presence of cachectin or tumor necrosis factor (TNF) associated with hypertriglyceridemia was demonstrated in the serum of patients with pulmonary tuberculosis. The
hyperlipidemia
that accompanies this infection may be mediated by the TNF inhibition of lipoprotein lipase activity. This sequence of events may be sufficient to explain, in part, the complex metabolic changes and
emaciation
observed in tuberculosis patients.
...
PMID:The role of cachectin/TNF in the pathogenesis of tuberculosis. 314 96
A new, spontaneously occurring diabetic syndrome has been observed in the aged males of an inbred strain of Wistar rats, WBN/Kob. The main clinical sign, glycosuria, was first detected at about 60 weeks of age, and thereafter some animals developed
hyperlipidaemia
and gradual
emaciation
. Prior to the onset of glucosuria, male rats showed impaired glucose tolerance after a glucose load at 21 weeks of age. The histopathologic lesions of the pancreas in the diabetic males consisted of multifocal fibrosis, decreased in number and size of islets and atrophy of exocrine tissue. Multifocal inflammatory foci of varying stages were the main pancreatic lesion in prediabetic male rats. This inflammatory change was detected even in 12-week-old rats and tended to occur around the islets. Therefore focal fibrosis and the decrease in the number and size of islets were considered to result from post-inflammatory scarring. The maturity-onset of this syndrome and the impaired glucose tolerance in younger animals suggested that diabetes mellitus of this rat strain is insulin-independent type II. However, the histological lesions of the pancreas were somewhat different from previous reports of both type I and II diabetes mellitus in man and animals.
...
PMID:A new diabetic strain of rat (WBN/Kob). 403 61
In reviewing the literature, no description of a
lipemia
occurring in relation to simple hemorrhage was found, so that the observation of the phenomenon here recorded would seem to be new. Very high percentages of fat have been found in the blood of diabetics. Fischer's case showed 18.1 per cent total ether extract. Of this very little was free fat (0.0018 gm. potassium hydroxide per gram of fat); iodine absorption was 60.6 per cent.; cholesterin, 2.6 per cent. Chatin's case, cited by Fischer, showed 1.2 per cent. cholesterin, 66.5 per cent. olein, 32.2 per cent. margarin in the fat. Neisser and Derlin in the ether extract of blood from a patient with diabetic coma found 19.7 per cent. fat, with melting point of from 39 degrees to 41 degrees C.; iodine absorption was 53.6 per cent. Javal in a similar case found 25.4 per cent. of fat in ether extract of dry serum (perhaps by Soxhlet method); 21 per cent. of the fat was lecithin. Bleibtreu produced alimentary
lipemia
in geese by feeding barley and butter. Ether extract of serum showed 6 per cent. of fat. The serum was milky with invisible droplets. Iodine absorption was 57 to 58 per cent. The fat was quite different, chemically, from the fat in the food. Lipemia disappeared a few days after discontinuing the forced feeding. Our experiments suggest, by analogy, the possible occurrence of
lipemia
in human anemias. In this connection it is of interest to note that we have recently demonstrated a moderate
lipemia
in a case of marked secondary anemia from hemorrhoids. The
emaciation
in such cases, as contrasted with the well-recognized conservation of the fat in pernicious anemia, suggests in human pathology a still further analogy which we now have under investigation. The fat in our lipemic rabbits differs from fats described above in its insolubility, as well as in its "constants." The change after precipitation of calcium from the serum suggests that the fat may be present in the serum as a protein-calcium-lecithin combination which is decomposed by decalcifying. While we are not prepared to offer an explanation of the mechanism of this
lipemia
, it is possible that the great loss of tissue proteins may have some influence on the abnormal fat metabolism. That the fat is derived from the tissues is a fair inference when its occurrence in connection with the loss of weight and the previous disappearance of the body fat are taken into consideration. A more careful study of the lipase in the blood and tissues is desirable. It may be that lowered oxidation following great loss of red cells plays a part.
...
PMID:EXPERIMENTAL LIPEMIA IN RABBITS. 1986 66
Trypanosomiasis caused by Trypanosoma evansi commonly produces wasting disease with signs of
emaciation
and cachexia mainly at the end stage. The present study was conducted to explore the possible hyperlipaemia or
hyperlipidaemia
and its association with cachexia-anorexia in equine trypanosomiasis. Out of the fifteen confirmed animals, none of the plasma sample was opaque. There was a significant increase in plasma triglyceride, total cholesterol and blood urea nitrogen and a highly significant increase in low-density lipoprotein (LDL) levels. A mild increase in high-density lipoprotein (HDL) and very low-density lipoprotein levels were observed, while the relative percentage of HDL and LDL was altered with high significance. A moderate increase in triglyceride and highly significant increase in LDL might be the reasons for retention of appetite and lipolysis. Possible protein breakdown and presence of lipolysis might be the reasons for cachexia in equine trypanosomiasis.
...
PMID:Hyperlipidaemia in trypanosomiasis of naturally infected horses: possible cachexia-anorexia syndrome? 2283 85
Patients with severe COPD are known to have comorbidities such as
emaciation
, cor pulmonale and right heart failure, muscle weakness,
hyperlipemia
, diabetes mellitus, osteoporosis, muscle atrophy, arterial sclerosis, hypertension, and depression. Therefore, treatment for COPD needs to focus on these comorbidities as well as the lungs. We previously reported a new mouse model of COPD utilizing the human surfactant protein C promoter SP-C to drive the expression of mature mouse IL-18 cDNA; constitutive IL-18 overproduction in the lungs of transgenic (Tg) mice induces severe emphysematous change, dilatation of the right ventricle, and mild pulmonary hypertension with aging. In the present study, we evaluated the progression of comorbidity in our COPD model. In female Tg mice, significant weight loss was observed at 16 weeks and beyond, when compared with control wild-type (WT) mice. This weight loss was suppressed in IL-13-deficient (knockout; KO) Tg mice. Muscle weight and bone mineral density were significantly decreased in aged Tg mice relative to control WT and IL-13 KO Tg mice. The aged Tg mice also showed impaired glucose tolerance. IL-18 and IL-13 may play important roles in the pathogenesis of comorbidity in COPD patients.
...
PMID:The progression of comorbidity in IL-18 transgenic chronic obstructive pulmonary disease mice model. 2456 45
Hyperlipidemia
is highly prevalent and is closely related to coronary heart disease which is the most common cause of death. Raised cholesterol is estimated to be responsible for 18% of cerebrovascular disease and 56% of ischemic heart disease. Overall, these diseases account for about 4.4 million deaths (7.9% of the total). Based upon the etiological factors and symptom complexes,
hyperlipidemia
can be considered as a part of Medoroga. Being a Tikshna formulation, the treatment modality of Lekhana Basti is aimed basically for Apatarpana (
emaciation
) of the body, as Basti is the fastest Apatarpana. In the present clinical trial, a total of 22 patients were registered of whom 19 patients completed the course of the therapy. Under randomization, the registered patients were divided into two groups of which group A was treated with Lekhana Basti and group B was administered standard control drug, i.e., Triphala Guggulu, for 21 days. The results of the study revealed that in patients treated with Lekhana Basti, there was a decrease of about 4.99% in S. cholesterol, 9.13% in S. low density lipoprotein (LDL), and 0.36% in S. apolipoprotein B. Lekhana Basti was found to have significant effect in reducing the symptoms of Medodushti and in reduction of objective parameters like weight, body mass index (BMI), body fat percentage, body circumferences such as chest, abdomen, hip, pelvis, mid-thigh circumference, etc., and skin fold thickness as biceps, triceps, mid-arm, and abdominal skinfold thickness.
...
PMID:Assessment of Lekhana Basti in the management of hyperlipidemia. 2469 69
Clausena lansium (Lour.) Skeels (Wampee) is widely grown in China and considered as a healthy fruit. Its leaves are also considered as traditional herbs. This study analyzed polyphenol compounds in polyphenol extracts of the leaves C. lansium (lour.) Skeels (PEL) and investigated the protective effect of PEL against hyperglycemia and
hyperlipidemia
in T2DM rats. The result showed that PEL is composed mainly of gallic acid, chlorogenic acid, coffee acid, ferulic acid, and rutin. PEL could obviously relieve some symptoms of T2DM rats, including
emaciation
, hyperhidrosis, polyphagia, diuresis, liver swelling, kidney, and pancreas hypertrophy, as well as reduce fasting blood glucose. Moreover, the supplementation of PEL significantly ameliorated lipids disorder and protected liver in T2DM rats, including fat accumulation, improvement of lipid distribution and hepatocyte protection. These results indicate that the Oral of PEL have potential effects of against hyperglycemia and
hyperlipidemia
in diabetic disorders.
...
PMID:Antidiabetic and Lipid-Lowering Effects of the Polyphenol Extracts from the Leaves of Clausena lansium (Lour.) Skeels on Streptozotocin-Induced Type 2 Diabetic Rats. 2922 35